Recursion Pharmaceuticals - Class A (RXRX)'s 30-day implied volatility (IV30) was 75.6% at the close on November 11, 2026, up from 67.0% the day before, against a 52-week range of 42.5% to 105.6%. Its 20-day historical volatility was 96.9%.
Data as of November 11, 2026.